Company: INDP
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001641172-25-005234
Chunk: 64

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 64
---
 Robert E. Martell, M.D., Ph.D.                                      |     |                    |    32,500 | -14 |     |                      |    * |   |
| All executive officers and directors as a group (11 persons)        |     |                    | 3,748,262 | -15 |     |                      | 20.6 | % |

* Less than one percent.

| (1) | Based                                                                                          
 solely upon a Schedule 13G/A filed with the SEC on August 17, 2023. 1,076,482 shares are       
 held by the Anderson Family Trust U/A/D January 7, 2017 in which Glen R. Anderson is a trustee 
 of the Anderson Family Trust and shares voting and dispositive control with his spouse, and    
 113,918 shares are held by Mr. Anderson over which he has sole voting and dispositive power.   
 The business address of Mr. Anderson is 101 South 200 East, Suite 700, Salt Lake City, UT      
 84111.                                                                                         |

| 40 |

| (2) | Consists                                                                                    
 of (i) 1,071,231 shares of common stock, and (ii) 1,071,231 shares of common stock issuable 
 upon exercise of warrants which are subject to either a 4.99% or 9.99% beneficial ownership 
 limitation. The amounts and percentages in the table do not give effect to such beneficial  
 ownership limitation.                                                                       |

| (3) | Consists                                                                                           
 of (i) 865,158 shares of common stock, and (ii) 779,142 shares of common stock issuable upon       
 exercise of warrants which are subject to either a 4.99% or 9.99% beneficial ownership limitation. 
 The amounts and percentages in the table do not give effect to such beneficial ownership           
 limitation.                                                                                        |

| (4) | Consists                                                                                    
 of (i) 1,212,837 shares of common stock, and (ii) 1,135,761 shares of common stock issuable 
 upon exercise of warrants which are subject to either a 4.99% or 9.99% beneficial ownership 
 limitation. The amounts and percentages in the table do not give effect to such beneficial  
 ownership limitation.                                                                       |

| (5) | Consists                                                                                        
 of (i) 1,341,524 shares of common stock held by the Michael J. Newman Trust,